Lotus Pharm vs WeLeader Biomedical: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and WeLeader Biomedical (7713) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ WeLeader Biomedical

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYWeLeader BiomedicalYoY
Oct 2026NT$2.13 billion-22.5%NT$112.6 million+15.3%
Sep 2026NT$2.77 billion+128.0%NT$116.6 million+16.8%
Aug 2026NT$2.11 billion+81.7%NT$116.2 million+14.8%
Jul 2026NT$2.49 billion+3.9%NT$120 million+26.4%
Jun 2026NT$3.4 billion+225.5%NT$112.9 million+15.2%
May 2026NT$2.32 billion+105.8%NT$111.3 million+20.6%
Apr 2026NT$3.09 billion+19.9%NT$115 million+38.8%
Mar 2026NT$4.35 billion+173.6%NT$102.3 million+14.3%
Feb 2026NT$2.24 billion+131.5%NT$78.3 million+4.6%
Jan 2026NT$2.05 billion-5.5%NT$98.3 million+21.7%
Dec 2025NT$2.44 billion+66.9%NT$96.6 million+21.0%
Nov 2025NT$1.06 billion-0.2%NT$100.9 million+14.7%
Oct 2025NT$2.75 billion+46.0%NT$97.7 million+22.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16